Study highlights the need for language services in cancer trials

Underrepresentation of racial and ethnic minority populations in cancer clinical trials persists partly because translation and interpretation services and resources are unavailable or inadequate in the United States, according to a Children’s Oncology Group (COG) study led by Columbia University School of Nursing. The updated study was published online in the Journal of the National Cancer Institute Cancer Spectrum on July 25, 2024, and will appear in the August 2024 journal issue.

MediLink and Roche partner on cancer drug development

Share this article Roche will gain sole international rights to develop, produce and market YL211. Credit: Marlon Trottmann / Shutterstock.com. MediLink Therapeutics has signed a

January 3, 2024

DDX41: A unique player in myeloid leukemogenesis

A new editorial paper was published in Oncotarget’s Volume 15 on July 2, 2024, entitled, “DDX41 and its unique contribution to myeloid leukemogenesis.”

July 20, 2024

A two-decade bet on Seagen pays off

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi there, Meghana here

April 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.